Komori
Fuso Chemical (4368) · InitiativeAdvanced

Cost reductions through price revisions, inventory reductions, and the consolidation and elimination of unprofitable product lines

First written in FY2016. 24 of 32 entries say "Restated". Latest entry: 2026-10-30.

32entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2019RestatedFY2023-Q1 – FY2025-H12016: 320162017: 320172018: 320182019: 420192020: 220202021: 420212022: 320222023: 320232024: 320242025: 220252026: 22026
Same theme, other companies
Improving Profitability by Selecting and Organizing Low-Margin Projects and Managing Costs Across the CompanyA theme 422 companies write about · 3 as a headwind · 447 as a tailwind

92 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 189 companies compared. The sentences above are computed from all 189.Comparing 200 of the theme's 450 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-10-30AdvancedRevisions to earnings forecasts

    「厳しい競争環境の中で進めた価格改定による販売単価の上昇」

    競争環境が厳しい中で価格改定が販売単価の上昇につながった実績を記載している。
  2. FY2026AdvancedAnnual report

    「To meet the demand forecast, the company decided to build new production facilities for ultra-high-purity colloidal silica at its Kyoto plant in March 2026, with an investment of ¥40 billion. Operations are scheduled to begin in February 2029, after which production capacity is expected to increase by 20% from fiscal 2025 levels. The company will also continue to build long-term relationships of trust with each customer, seek agreement on customers' share of the costs of the new capital investment, and plans to revise prices by 5–10% from fiscal 2026 onward.」

    As a response to higher raw material and capital investment costs, the company has specified price revisions of 5–10% from fiscal 2026 onward, including customer cost sharing.
  3. FY2026-H1Lower selling pricesAnnual report

    「In overseas markets, efforts to increase the share of malic acid led to higher sales volumes, mainly in Asia, while intensifying competition caused selling prices to decline. In addition, lower export sales and sales at overseas subsidiaries resulting from the stronger yen caused segment revenue to fall below that of the previous interim consolidated accounting period.」

    While expanding sales, the company has experienced lower selling prices due to intensifying competition and lower sales due to the stronger yen, indicating a change in business conditions surrounding its pricing response.
  4. FY2025AdvancedAnnual report

    「The company implemented a price revision from February 2025. Overseas, it worked to maintain its share in Asian markets, increase volumes as demand recovered, and recapture volume in Europe and North America through strategic pricing. As a result, selling prices declined by 10% after conversion into yen and by 15% in US dollar terms, but the company recovered its share in overseas markets.」

    The company implemented a price revision in February 2025 and is pursuing a recovery in overseas market share and volumes despite the accompanying price decline.
  5. FY2025-H1RestatedAnnual report

    「Operating profit fell below that of the previous interim consolidated accounting period, resulting in higher revenue but lower profit. Although ongoing selling price revisions had a positive effect, profit was affected by higher import and energy prices resulting from the weaker yen and lower production volumes because scheduled maintenance was carried out for a longer period than usual.」

    The company continues to revise selling prices, while saying that higher import and energy prices resulting from the weaker yen and lower production volumes due to scheduled maintenance weighed on profit.
  6. FY2024RestatedAnnual report

    「In fiscal 2024, the company aims to increase profit by expanding sales volumes in overseas markets through sales expansion driven by strategic pricing.」

    The company continues its policy of addressing higher raw material and energy prices through price revisions and pricing, while expanding sales volumes in overseas markets.
  7. FY2024-Q3RestatedAnnual report

    「Operating profit fell below that of the cumulative period of the previous quarter, resulting in lower revenue and lower profit. Although ongoing selling price revisions had a positive effect, profit was affected by lower sales and higher costs from production adjustments, increased depreciation due to the operation of new equipment, higher import prices resulting from the weaker yen and higher energy prices, among other factors.」

    The company continues to revise selling prices, while saying that lower sales, production adjustments and higher depreciation, import prices and energy prices were cost factors.
  8. FY2024-Q2RestatedAnnual report

    「Operating profit also fell below that of the cumulative period of the previous quarter, resulting in lower revenue and lower profit. Although the weaker yen had a positive effect, profit was affected by lower sales, higher depreciation and start-up costs associated with the full-scale operation of new equipment at the Kashima plant, higher energy prices and higher costs caused by lower operating rates.」

    The company says that although price revisions and the weaker yen had positive effects, higher depreciation and start-up costs for new equipment, higher energy prices and higher costs from lower operating rates weighed on profit, and it continues its pricing and cost management efforts.
  9. FY2023RestatedAnnual report

    「The company worked to absorb higher logistics costs through efficiency improvements, while responding by passing some of the increase through to prices after discussions with customers.」

    The company continues its established approach to higher raw material, logistics and energy prices, combining efficiency improvements with price pass-through following discussions with customers.
  10. FY2023-Q3RestatedAnnual report

    「For other products as well, the company continues to revise selling prices in response to soaring raw material and import prices.」

    The company continues to revise selling prices in response to soaring raw material and import prices.
  11. FY2023-Q2RestatedAnnual report

    「For other products as well, the company continues to revise selling prices in response to soaring raw material and import prices.」

    The company continues to revise selling prices in response to soaring raw material and import prices.
  12. FY2023-Q1RestatedAnnual report

    「For other products as well, the company continues to revise selling prices in response to soaring raw material and import prices.」

    The company continues to respond to soaring raw material and import prices through selling price revisions.
  13. FY2022AdvancedAnnual report

    「The company responded to substantial increases in raw material and purchase prices by implementing multiple price revisions while securing customers' understanding.」

    In response to higher raw material and purchase prices, the company implemented multiple price revisions, putting price pass-through into practice.
  14. FY2022-Q2RestatedAnnual report

    「In Japan, raw material prices continued to rise, and selling prices increased for products whose contracts link selling prices to raw material prices.」

    In response to soaring raw material prices, selling prices have increased under contracts linked to raw material prices. No material change in the company's pricing response or cost management policy has been indicated.
  15. FY2022-Q1RestatedAnnual report

    「Raw material prices turned higher, and selling prices increased for products whose contracts link selling prices to raw material prices.」

    In response to higher raw material prices, selling prices have increased under contracts linked to raw material prices. No new change in the company's pricing response has been indicated.
  16. FY2021RestatedAnnual report

    「If procurement prices rise, the company will respond through various cost reductions and a review of its earnings structure, as well as by revising selling prices.」

    The company maintains its policy of addressing higher raw material prices through a combination of cost reductions, a review of its earnings structure and selling price revisions.
  17. FY2021-Q3RestatedAnnual report

    「Operating profit fell below that of the cumulative period of the previous quarter, resulting in lower revenue and lower profit, as the effect of cost reductions from lower raw material prices was outweighed by higher costs from increased depreciation on new equipment and lower sales.」

    The company recognizes the cost savings from lower raw material prices, while saying that higher depreciation on new equipment and lower sales weighed on profit.
  18. FY2020AdvancedAnnual report

    「Operating profit exceeded that of the previous fiscal year, resulting in lower revenue but higher profit, due to progress in bringing selling prices into line through continuous price revisions, solid performance at overseas subsidiaries, lower raw material prices and lower import prices resulting from the stronger yen, among other factors, despite higher costs from increased depreciation.」

    The company says that continuous price revisions brought selling prices more closely into line with market conditions and, together with lower raw material and import prices, contributed to improved profit in the Life Science business.
  19. FY2020-Q3RestatedAnnual report

    「Operating profit exceeded that of the cumulative period of the previous quarter, resulting in lower revenue but higher profit, due to progress in bringing selling prices into line through continuous price revisions, solid performance at overseas subsidiaries, lower raw material prices and lower import prices resulting from the stronger yen, among other factors.」

    The company continues to say that continuous price revisions have brought selling prices more closely into line with market conditions. It also cites lower raw material and import prices as factors contributing to improved profit.
  20. FY2020-Q2RestatedAnnual report

    「Operating profit exceeded that of the cumulative period of the previous quarter, resulting in lower revenue but higher profit, due to progress in bringing selling prices into line through continuous price revisions, solid performance at overseas subsidiaries, lower raw material prices and lower import prices resulting from the stronger yen, among other factors.」

    The company continues to say that continuous price revisions have brought selling prices more closely into line with market conditions. It also cites lower raw material and import prices as factors contributing to improved profit.
  21. FY2020-Q1AdvancedAnnual report

    「Operating profit exceeded that of the cumulative period of the previous quarter, resulting in lower revenue but higher profit, due to progress in bringing selling prices into line through continuous price revisions and solid performance at overseas subsidiaries, among other factors.」

    The company says that continuous price revisions brought selling prices more closely into line with market conditions and contributed to improved operating profit in the Life Science business.
  22. FY2019RestatedAnnual report

    「The company worked to expand sales in Japan and overseas and revise selling prices in response to fluctuations in key raw material prices.」

    The company continues to expand sales in Japan and overseas and revise selling prices in response to fluctuations in raw material prices.
  23. FY2019-Q3RestatedAnnual report

    「The company worked to expand sales in Japan and overseas and revise selling prices in response to higher prices for key raw materials.」

    The company continues to revise selling prices in response to higher prices for key raw materials and pursue cost reductions.
  24. FY2019-Q2RestatedAnnual report

    「The company worked to expand sales in Japan and overseas and revise selling prices in response to higher prices for key raw materials.」

    The company continues to revise selling prices in response to higher prices for key raw materials. Although it also worked to reduce costs, higher raw material and import purchase prices weighed on profit.
  25. FY2019-Q1RestatedAnnual report

    「The company worked to expand sales in Japan and overseas and revise selling prices in response to higher prices for key raw materials.」

    The company continues to revise selling prices in response to higher prices for key raw materials. Although it also worked to reduce costs, higher raw material and import purchase prices weighed on profit.
  26. FY2018-Q3RestatedAnnual report

    「In Japan, the company worked to expand sales of fruit acids, including malic acid and citric acid, increase sales of industrial products, and revise selling prices in response to higher prices for key raw materials. Operating profit exceeded the year-earlier level because, despite the impact of the Kyoto No. 1 Plant shutdown associated with capital investment, manufacturing costs declined through cost reductions and sales volumes increased.」

    The company continues to revise selling prices in response to higher prices for key raw materials and reduce manufacturing costs through cost reductions.
  27. FY2018-Q2RestatedAnnual report

    「Operating profit exceeded the year-earlier level due to lower product costs from advance production in preparation for plant shutdowns associated with capital investment and scheduled maintenance in the second half, as well as cost reductions and higher sales volumes.」

    The company continues to improve costs and profit through advance production in preparation for capital investment and scheduled maintenance, cost reductions and selling price revisions.
  28. FY2018-Q1RestatedAnnual report

    「In Japan, the company worked to expand sales of fruit acids, including malic acid and citric acid, increase sales of industrial products, and revise selling prices in response to higher prices for key raw materials.」

    The company continues to revise selling prices in response to higher prices for key raw materials and improve costs and profit through cost reductions.
  29. FY2017-Q3RestatedAnnual report

    「Operating profit exceeded the year-earlier level because, although production stoppages caused by planned large-scale capital investment construction affected manufacturing costs, product costs declined due to lower purchase prices resulting from the stronger yen and cost reductions.」

    The company continues to report lower costs through reduced purchase prices and cost reductions, despite the impact of production stoppages caused by plant construction.
  30. FY2017-Q2RestatedAnnual report

    「Operating profit exceeded the year-earlier level because, in addition to lower purchase prices resulting from the stronger yen and cost reductions, the company brought forward production during the first six months of the fiscal year under review at the Kyoto plant of its Electronic Materials and Functional Chemicals business, in preparation for production stoppages caused by large-scale capital investment construction scheduled for the second half of the fiscal year under review. As a result, product costs declined.」

    The company says product costs declined through cost reductions and advance production in preparation for plant construction work.
  31. FY2017-Q1RestatedAnnual report

    「Operating profit exceeded the year-earlier level because, in addition to lower purchase prices resulting from the stronger yen and cost reductions, the company brought forward production during the first quarter of the fiscal year under review at the Kyoto plant of its Electronic Materials and Functional Chemicals business, in preparation for production stoppages caused by large-scale capital investment construction scheduled for the summer and winter of the fiscal year under review. As a result, product costs declined.」

    The company says product costs declined through cost reductions and advance production, but has not disclosed any new quantitative targets for these measures.
  32. FY2016First statedAnnual report

    「To avoid a decline in profit caused by foreign exchange movements, the company is implementing timely price revisions while reducing inventory volumes, disposing of obsolete inventory and cutting costs by consolidating unprofitable products. Qingdao Fuso Refining and Processing Co., Ltd. in China, where manufacturing costs are rising due to higher wages and prices, is also pursuing cost reductions, as in Japan.」

    The company is addressing foreign exchange movements and rising manufacturing costs in China by combining price pass-through with inventory and product portfolio management.
Moved together

"Integrated strengthening of management resources, production systems, raw-material procurement and cost competitiveness" moved the same way as this thread, in the same document, in 5 of its 32 moves.

555444★123456
  1. ★This thread
  2. 1Integrated strengthening of management resources, production systems, raw-material procurement and cost competitiveness5×
  3. 2Deepening our involvement in the semiconductor field and responding to miniaturization and higher integration5×
  4. 3Application of Core Technologies and Development of New Products Addressing Customer Needs5×
  5. 4Aiming to become the world's No. 1 malic acid manufacturer4×
  6. 5Disasters and Accidents Involving Manufacturing and Research Facilities4×
  7. 6Establishing the FUSO Brand and Expanding Sales in Asia4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Fuso Chemical's next results are scheduled for 2026-10-30. Read the earnings preview It last moved in the Revisions to earnings forecasts of 2026-10-30: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.